Cooperação internacional num mundo não ideal: o exemplo do COVAX

Autores

DOI:

https://doi.org/10.17566/ciads.v10i3.789

Palavras-chave:

Cooperação internacional, Nacionalismo vacinal, Acesso às vacinas COVID-19, Justiça global

Resumo

O mundo foi testemunha de uma das respostas mais rápidas da história a uma nova doença em termos de desenvolvimento de medicamentos e vacinas. No entanto, apesar do facto de que as vacinas seguras e eficazes para COVID-19 foram desenvolvidas a um ritmo notável, a cooperação internacional parece ter falhado no que diz respeito à distribuição global equitativa de vacinas. Este artigo explora os desafios para a cooperação internacional em matéria de saúde global e, especificamente, para a distribuição justa de vacinas à escala global. Apresentaremos os principais obstáculos aos esforços cooperativos e uma resposta interessante, como o mecanismo COVAX, um esquema de redistribuição cooperativa que foi lançado recentemente pela OMS, CEPI e Gavi. Considerando o COVAX como um primeiro passo louvável e necessário para melhorar a cooperação internacional em saúde, argumentamos que o mecanismo precisa de identificar as áreas de potencial melhoria.

Biografia do Autor

Florencia Luna, Facultad Latinoamericana de Ciencias Sociales (FLACSO)

Doctor; Bioethics Program Director,Facultad Latinoamericana de Ciencias Sociales (FLACSO), Bioethics Program, Ciudad de Buenos Aires, Argentina; principal researcher at National Council of Research in Science and Technology (CONICET). https://orcid.org/0000-0001-8865-2756. E-mail: florlunaflacso@gmail.com

Dr. Luna acknowledges that research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number R25TW001605. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.

Felicitas Holzer, Institute of Biomedical Ethics and History of Medicine, University of Zurich

PhD, Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland. https://orcid.org/0000-0002-3674-0241 . E-mail: felicitas.holzer@ibme.uzh.ch

Referências

Bollyky TJ, Bown CP. The Tragedy of Vaccine Nationalism: Only Cooperation Can End the Pandemic. Foreign Affairs. 2020;99(5):96.

Lambert J. Global inequity in COVID-19 vaccination is more than a moral problem. ScienceNews [internet]. February 2021. Available at: https://www.sciencenews.org/article/covid-19-global-inequity-vaccines-deaths-economy-pandemic

Emanuel E, Fabre C, Halliday D. et al. How many vaccine doses can nations ethically hoard? Foreign Affairs. March 9, 2021. Available at: https://www.foreignaffairs.com/articles/world/2021-03-09/how-many-vaccine-doses-can-nations-ethically-hoard

Gavi, The Vaccine Alliance. What is COVAX? COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. 2020. Available at: https://www.gavi.org/covax-facility#what

World Health Organization (WHO). COVAX Announces new agreement, plans for first deliveries. January 22, 2021. Available at: https://www.who.int/news/item/22-01-2021-covax-announces-new-agreement-plans-for-first-deliveries

International Chamber of Commerce (ICC). Study shows vaccine nationalism could cost richt countries USD 4.5 trillion. January 25, 2021. Available at: https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/

Andreoni M, Lodoño E, Casado L. Brazil’s Covid Crisis Is a Warning to the Whole World, Scientists Say. New York Times. March 4, 2021. Available at: https://www.nytimes.com/2021/03/03/world/americas/brazil-covid-variant.html

World Health Organization. Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility. 9 September 2020. Available at: https://www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility

Emanuel EJ, Persad G, Kern A, Buchanan A, Fabre C, Halliday D et al. An ethical framework for global vaccine allocation. Science. Sept 2020;369(6509):1309-1312.

Emanuel E, Luna F, Schaefer O, Tan KC, Wolff J. Enhancing the WHO`s proposed framework for distributing COVID-19 vaccines among countries. AJPH. Mar. 2021;111(3): 371-373. Available at: https://ajph.aphapublications.org/doi/10.2105/AJPH.2020.306098

Worldmeters. COVID-19 coronavirus pandemic. Update March 12, 2021.

Available at: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1

Frenk J, Moon S. Governance challenges in global health. The New England Journal of Medicine. March 2013;368(10):936– 942. doi: 10.1056/NEJMra1109339

Van de Pas R, Hill PS, Hammonds R, Ooms G, Forman L, Waris A et al. Global health governance in the sustainable development goals: Is it grounded in the right to health?. Global Challenges. 2017;1:47-60. doi: 10.1002/gch2.1022.

Pan American Health Organization (PAHO). PAHO Revolving Fund. Available at: https://www.paho.org/en/resources/paho-revolving-fund

Nagel T. The problem of global justice. Philosophy & Public Affairs. April 2005;33(2):113–147.

Downloads

Publicado

16-09-2021

Como Citar

1.
Luna F, Holzer F. Cooperação internacional num mundo não ideal: o exemplo do COVAX. Cad. Ibero Am. Direito Sanit. [Internet]. 16º de setembro de 2021 [citado 28º de outubro de 2021];10(3):199-210. Disponível em: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/789

Edição

Seção

COMUNICAÇÃO BREVE